Lp-PLA2 ASSAYS AND COMPOSITION WITH DETERGENT

BIOSENSOR FOR TRIGLYCERIDES

REAGENT COMPOSITION AND KIT

COMPOSITIONS, DEVICES, AND METHODS OF MITIGATING LIPOPROTEIN INTERFERENCE IN IN VITRO DIAGNOSTIC ASSAYS FOR HYDROPHOBIC ANALYTES

DIAGNOSIS AND TREATMENT OF CONGESTIVE COLON FAILURE (CCF)

AN EXTRACTION PROCESS OF PANCRELIPASE AND EVALUATION THREOF

METHOD FOR SIZE BASED EVALUATION OF PANCREATIC PROTEIN MIXTURE

SELF-IMMOLATIVE PROBES FOR ENZYME ACTIVITY DETECTION

LIPASE-MODIFIED STRAIN

Compositions, devices, and methods of mitigating lipoprotein interference in in vitro diagnostic assays for hydrophobic analytes

System, apparatus and method for training a subject

FLUORESCENT PROBES FOR MONOACYLGLYCEROL LIPASE (MAGL)

Lp-PLA2 ASSAYS AND COMPOSITION WITH DETERGENT

Compositions, devices, and methods of mitigating lipoprotein interference in in vitro diagnostic assays for hydrophobic analytes

NOVEL BIOSENSOR AND RELATED WOUND DRESSING SYSTEM

Self-immolative probes for enzyme activity detection

METHOD FOR EVALUATION OF DRUG EFFICACY OF A MEDICINE HAVING A THERAPEUTIC OR PREVENTIVE EFFECT AGAINST A DISEASE RELATED TO EL ACTIVITY AND A METHOD FOR SCREENING AN INHIBITOR OF EL ACTIVITY

Rapid, low-sample-volume cholesterol and triglyceride assays

Measurement of Lp-PLAactivity

Method For Quantifying Plasmalogens Using PLA1 Processing

Lysosomal acid lipase and PPAR gamma ligands as immune therapies for cancer treatment

Compositions and methods for detecting and quantifying host cell protein in cell lines and recombinant polypeptide products

Compositions and methods for detecting and quantifying host cell protein in cell lines and recombinant polypeptide products

Method for quantifying plasmalogens using PLA1 processing

Suppression of SPLA2-integrin binding for treating an inflammatory condition or suppressing cell proliferation

Lp-PLA2 assays and composition with detergent

SYSTEMS AND METHODS FOR CHARACTERIZATION OF HYPERTRIGLYCERIDEMIA

TREATMENT OF AUTOPHAGY-RELATED DISORDERS

Systems and methods for electrochemical triglycerides assays

METHOD FOR EVALUATION OF DRUG EFFICACY OF A MEDICINE HAVING A THERAPEUTIC OR PREVENTIVE EFFECT AGAINST A DISEASE RELATED TO EL ACTIVITY AND A METHOD FOR SCREENING AN INHIBITOR OF EL ACTIVITY

Rapid, low-sample-volume cholesterol and triglyceride assays

Process for producing substrate solution for measuring lipase activity, and method for simplifying production

DETECTION, MONITORING AND TREATMENT OF ACUTE MYOCARDIAL INFARCTION

sPLA2 MONITORING STRIP

Fluorescent labeled inhibitors

Protein fluorescent nanoparticles and methods of synthesis thereof

Compositions and methods for detecting and quantifying host cells protein in cell lines and recombinant polypeptide products

Use of at least one substrate of carboxylesterase and/or triacylglycerol lipase for detecting bacteria of the group

Swatch for Testing Lipase Activity

Inhibitors Of Fatty Acid Amide Hydrolase And Monoacylglycerol Lipase For Modulation Of Cannabinoid Receptors

TREATMENT OF AUTOPHAGY-RELATED DISORDERS

Rapid, low-sample-volume cholesterol and triglyceride assays

Measurement method for human pancreatic lipase activity

Electrochemiluminescence (ECL) detection reagents and related methods for measuring enzyme activity

Method for evaluation of drug efficacy of a medicine having a therapeutic or preventive effect against a disease related to EL activity and a method for screening an inhibitor of EL activity

MARKER ASSOCIATED WITH NON-ALCOHOLIC STEATOHEPATITIS

LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 ANTIBODY COMPOSITIONS AND METHODS OF USE

METHOD USING FLUORESCENT TURN-ON PROBES FOR CELL-SPECIFIC DETECTION

METHODS FOR DETECTION OF HEART FAILURE

VALUE-ASSIGNED SOLUTIONS OF LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 HAVING A LONG SHELF-LIFE

METHODS FOR MONITORING NEUROINFLAMMATORY DESTRUCTION OF NEURONS AND FOR TREATING DISEASES HAVING AN INFLAMMATORY COMPONENT RELATED TO PHOSPHOLIPASE A2

sPLA2 MONITORING STRIP

PLA2ACTIVITY AS A MARKER FOR OVARIAN AND OTHER GYNECOLOGIC CANCERS

Method for Measuring Low-Density Lipoprotein (LDL) Cholesterol and Test Piece for Measuring LDL Cholesterol

Combination of sPLA2 type IIA mass and OXPL/APOB cardiovascular risk factors for the diagnosis/prognosis of a cardiovascular disease/event

Marker associated with non-alcoholic steatohepatitis

Method for treatment of cachexia by administering inhibitors of adipose triglyceride lipase expression or activity

Secreted phospholipase A2 biomarkers for arthritis

METHODS OF DIAGNOSING INSULIN RESISTANCE AND SENSITIVITY

MARKERS RELATED TO AGE-RELATED MACULAR DEGENERATION AND USES THEREFOR

Enzymatic Assay for the Quantitative Determination of Phospholipase A1 or A2 Activity in a Sample

MODULATORS OF MONOGLYCERIDE LIPASE IN THE TREATMENT OF ACNE, OF SEBORRHOEIC DERMATITIS OR OF HYPERSEBORRHOEA

Inhibitors of fatty acid amide hydrolase and monoacylglycerol lipase for modulation of cannabinoid receptors

METHOD OF PREDICTING DRUG-INDUCED PHOSPHOLIPIDOSIS

Method for measuring low-density lipoprotein (LDL) cholesterol

Alternative crystal form of monoacylglycerol lipase (MGLL)

METHODS FOR PREDICTING AND DETECTING INTOLERANCE TO AN HYPOLIPIDEMIC AGENT

Methods of identifying a subject having or at risk of having or developing coronary artery disease

Dry analytical element for lipase measurement

Dry analytical element for lipase measurement

Methods for treating diseases having an inflammatory component related to phospholipase A2

Dry analytical element for lipase measurement